Skip to main content
. 2021 Jul 28;11:15308. doi: 10.1038/s41598-021-94052-4

Figure 6.

Figure 6

Inhibiting sphingosine kinases reduces PAR1-AP induced platelet aggregation. Washed human platelets (2 × 108/mL) were pre-incubated with vehicle control (0.2% methanol) or sphingosine kinase inhibitors for 5 min. Platelet aggregation was induced by maximal (1.5–2.0 μM) concentration of PAR1-AP and recorded for 5 min. (a) Representative traces of maximal concentration PAR1-AP induced platelet aggregation in the absence or presence of (i) 10 μM SPHK1/2 inhibitor DMS (N, N-Dimethylsphingosine), (ii) 1 μM SPHK1 inhibitor PF543 hydrochloride or (iii) 10 μM SPHK2 inhibitor SLM 6,031,434, respectively. (b) Bar graphs of (i) quantified percentage aggregation and (ii) AUCs induced by maximal concentration of PAR1-AP alone or in the presence of SPHK inhibitors. AU: arbitrary unit. Data are plotted as mean ± standard error of the mean. N = 5. Statistical analysis: Student’s paired t-test. ns = not significant, *P < 0.05, **P < 0.01, ***P < 0.001.